SweetValueLab
Write for us

PulteGroup, Inc. — Wall Street Analyst Estimates & Price Targets

PHM
NYSEConsumer CyclicalResidential ConstructionCIK 0000822416pultegroupinc.comAbout PHM
Last close · Oct 16, 2026113.55+0.56 (+0.50%)
Market cap$21.6B

11 firms' latest targets, last 90 days: median $138.00 ($110.00–$166.00), 22% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$120$140$160NovJan 2026MarMayJulSep2025-10-22 · Evercore ISI: $1342025-12-08 · Barclays: $1152026-01-06 · UBS: $1592026-01-09 · RBC Capital: $1112026-01-13 · Goldman Sachs: $1442026-01-30 · RBC Capital: $1152026-01-30 · Oppenheimer: $1492026-02-04 · Raymond James: $1452026-04-16 · Truist: $1502026-04-24 · UBS: $1622026-04-24 · Evercore ISI: $1512026-04-24 · Wells Fargo: $1402026-07-14 · Barclays: $1232026-07-23 · UBS: $1662026-07-23 · RBC Capital: $1162026-07-23 · Evercore ISI: $1622026-07-23 · Barclays: $1242026-08-24 · Wolfe Research: $1582026-08-24 · Wolfe Research: $1292026-09-11 · Wells Fargo: $1452026-09-16 · Truist: $1362026-10-01 · Morgan Stanley: $1282026-10-06 · Melius Research: $1322026-10-06 · Barclays: $1102026-10-08 · Piper Sandler: $1452026-10-12 · Goldman Sachs: $138
$120$140$160NovFebMayAug

Each firm's latest target

last 90 days · 11 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-12Goldman Sachs$138.00$144.00▼ 4%+23%+22%
2026-10-08Piper Sandler$145.00——+29%+28%
2026-10-06Melius Research$132.00——+16%+16%
2026-10-06Barclays$110.00$124.00▼ 11%-3%-3%
2026-10-01Morgan Stanley$128.00——+10%+13%
2026-09-16Truist$136.00$150.00▼ 9%+14%+20%
2026-09-11Wells Fargo$145.00$140.00▲ 4%+25%+28%
2026-08-24Wolfe Research$158.00$129.00▲ 22%+22%+39%
2026-07-23UBS$166.00$162.00▲ 2%+35%+46%
2026-07-23RBC Capital$116.00$115.00▲ 1%-6%+2%
2026-07-23Evercore ISI$162.00$151.00▲ 7%+32%+43%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2021reported$13.9B+26%$7.43+43%est. $13.7B+1%est. $7.154
2022reported$16.2B+17%$11.01+48%est. $15.6B+4%est. $10.163
2023reported$16.1B-1%$11.72+6%est. $16.2B-1%est. $11.659
2024reported$17.9B+12%$14.69+25%est. $17.6B+2%est. $13.519
2025reported$17.3B-4%$11.12-24%est. $17.0B+2%est. $11.367
2026$16.3B-6%$10.06-11%$16.2B–$16.5B$9.74–$10.3210
2027$16.9B+3%$10.92+8%$16.5B–$17.2B$10.26–$11.3811
2028$17.9B+6%$12.43+14%$17.2B–$19.3B$10.72–$13.806
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.